Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARTEMISIA: Nebivolol and Ramipril in Uncontrolled Hypertension
NCT06104423Phase 4Completed
- Sponsor
- Menarini Group
- Start
- Oct 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nebivolol, ramipril in hypertension (HTN), sponsored by Menarini Group. Started Oct 2023; status: completed.
02
Drugs
nebivololramipril
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT06104423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06104423.